Prostate Cancer
📧 Sign up to get email alerts when something new happens for Prostate Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-01Clinical Trial Update: MATCH-UP: MAking Telehealth-Delivery of Cancer Care at Home Effective and Safe-Upscaled: A Pragmatic Cluster Randomized Trial [NA]
This clinical trial update describes MATCH-UP, a pragmatic cluster randomized trial evaluating telehealth-delivered cancer care at home for …
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: Prevalence of the c.853delT Mutation of the HOXB13 Gene in Prostate Cancer in Martinique [NA]
A completed clinical trial update reporting the prevalence of the HOXB13 c.853delT mutation in prostate cancer patients in Martinique.
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: Prostate Cancer With OligometaSTatic Relapse: Combining Stereotactic Ablative Radiotherapy and Durvalumab (MEDI4736) [Phase 2]
A Phase 2 study evaluating the combination of stereotactic ablative radiotherapy and durvalumab (MEDI4736) for oligometastatic relapse in pr…
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: Contributions of a Paramedical Approach in the Prevention and Treatment of Side Effects Associated With Radical Prostatectomy [NA]
An update on a clinical trial evaluating a paramedical approach to prevent and treat side effects following radical prostatectomy in prostat…
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: Adaptive Radiation Therapy (ART) Stereotactic Ablative Body Radiotherapy (SABR) for Primary Localized Prostate Cancer [NA]
Mayo Clinic is recruiting for a study evaluating adaptive radiation therapy with stereotactic ablative body radiotherapy for primary localiz…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: Quality of Life in Prostate Cancer Patients
Clinical trial update noting quality-of-life research in prostate cancer patients; the study is currently active but not recruiting.
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: Fc-Engineered Anti-CTLA-4 Monoclonal Antibody in Advanced Cancer [Phase 1]
This Clinical Trials Update describes a Phase 1 study of an Fc-engineered anti-CTLA-4 monoclonal antibody by Agenus in patients with advance…
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: FDG-PET-Guided Metastasis Directed Radiation Therapy for the Treatment of Metastatic Hormone Sensitive Prostate Cancer, The PRTY Trial [Phase 2]
Phase 2 PRTY Trial evaluating FDG-PET-guided metastasis-directed radiation therapy for metastatic hormone-sensitive prostate cancer; current…
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: Cohort Evaluation of Body Fluids Early Detection of Cancer in High-risk Individuals [NA]
A trial update describing a Gustave Roussy-led study evaluating body fluids for early cancer detection in high-risk individuals, with a broa…
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: SBRT Boost for Unfavorable Prostate Cancer' [NA]
A clinical trial is recruiting to evaluate an SBRT boost for unfavorable prostate cancer, sponsored by MemorialCare Health System.
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: Evaluating the Implementation of a Comprehensive Multilevel Virtual Oncology Program Among Veterans Diagnosed With Lung, Colorectal, Prostate, and Breast Cancers in the US Department of Veterans Affairs
A clinical trial update describing the ongoing recruitment and implementation of a comprehensive multilevel virtual oncology program for vet…
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: NEWPROMRI-PATHWAY - A New Prostate Magnetic Resonance Imaging (MRI) Pathway
This entry describes the NEWPROMRI-PATHWAY trial, evaluating a new MRI-based pathway for prostate cancer. The study is currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: Adjuvant Curcumin to Assess Recurrence Free Survival in Patients Who Have Had a Radical Prostatectomy [Phase 3]
This ClinicalTrials.gov entry reports a Phase 3 trial evaluating adjuvant curcumin to improve recurrence-free survival after radical prostat…
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: COAST Therapy in Advanced Solid Tumors and Prostate Cancer [Phase 1, Phase 2]
Clinical trial update on COAST Therapy for advanced solid tumors and recurrent prostate cancer, currently recruiting for Phase 1 and Phase 2…
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: SPECT Imaging for Pharmacokinetics and dosimEtry Towards TREATment Optimization
Clinical trial update describing a study using SPECT imaging to characterize pharmacokinetics and dosimetry to optimize cancer treatment, cu…
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: Real-world Use of Lutetium (177Lu) Vipivotide Tetraxetan in China(PSMAreal CN)
This clinical trial update reports recruitment for real-world use of Lutetium-177 Lu vipivotide tetraxetan in China for metastatic prostate …
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: Salvage Moderate Hypofractionated Versus Ultrahypofractionated Radiotherapy for Biochemical Recurrence After Radical Prostatectomy in Prostate Cancer [Phase 3]
Phase 3 clinical trial comparing salvage moderate hypofractionated versus ultrahypofractionated radiotherapy for biochemical recurrence afte…
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: Stockholm3 Test Validation in Men on Active Surveillance in Switzerland (CHAS3 Trial)
The CHAS3 trial is validating the Stockholm3 diagnostic test in men with prostate cancer on active surveillance in Switzerland, and recruitm…
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: Outpatient Laparoscopic Radical Prostatectomy
A clinical trial update indicates that the outpatient laparoscopic radical prostatectomy study sponsored by GCS Ramsay Santé pour l'Enseigne…
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: Imperial Prostate 9 - ATLAS (Approaches To Long-Term Active Surveillance) [NA]
This entry notes that Imperial Prostate 9—ATLAS (Approaches To Long-Term Active Surveillance) for prostate cancer is currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: The Use of Nanoparticles to Guide the Surgical Treatment of Prostate Cancer [Phase 1]
This document reports a Phase 1 clinical trial investigating nanoparticle-based methods to guide surgical treatment of prostate cancer, curr…
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: A Single-Arm Phase II Study of Neoadjuvant Intensified Androgen Deprivation (Leuprolide and Abiraterone Acetate) in Combination With AKT Inhibition (Capivasertib) for High-Risk Localized Prostate Cancer With PTEN Loss [Phase 2]
Phase II single-arm neoadjuvant trial evaluating intensified androgen deprivation with leuprolide and abiraterone acetate plus the AKT inhib…
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: Ultra-hypofractionated Carbon-ion Therapy for Prostate Cancer [Phase 1]
A Phase 1 clinical trial is planned to evaluate ultra-hypofractionated carbon-ion therapy for prostate cancer, with the study currently not …
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: FFOCT for the Diagnosis of Prostate Cancer
A completed clinical trial evaluating FFOCT as a diagnostic tool for prostate cancer in men with a PSA of 4.0 ng/mL.
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: Multiparametric Magnetic Resonance Imaging of the Prostate to Assess Disease Progression and Genomics in Patients Undergoing Active Surveillance for Prostate Cancer [NA]
A National Cancer Institute study is using multiparametric MRI and genomic profiling to evaluate disease progression in men with prostate ca…